Spatially Resolved Transcriptomics For Sequencing Service Promotion

Empowering Genomics with Spatially Contextualized Multi-Omics and High-Throughput Automation Solutions

Featured Spatial Services

Leading Spatial Biology Technologies

Discover our highly resolved spatial transcriptomics and sequencing pipelines designed to preserve spatial context and unlock deep biological insights.

The Evolution and Industrial Rise of Spatially Resolved Transcriptomics

In the landscape of modern genomics, Spatially Resolved Transcriptomics (SRT) has transitioned from a specialized academic breakthrough to a cornerstone of industrial and clinical biotechnology. Traditional bulk RNA sequencing provides an average gene expression profile across a heterogeneous tissue sample, masking cell-to-cell variations. While single-cell RNA sequencing (scRNA-seq) solved this resolution bottleneck by profiling individual cells, it did so at the cost of losing critical spatial coordinates. Spatially Resolved Transcriptomics bridges this gap, allowing researchers to visualize and map gene expression profiles directly within the intact tissue architecture.

This capability is transforming the life science industry, particularly in clinical diagnostics, drug discovery, and translational research. By preserving the spatial context, researchers can investigate how cells interact with their immediate microenvironment. This is proving invaluable for understanding complex biological systems, such as the spatial dynamics of immune infiltration in tumors, the layered architecture of the mammalian brain, and the localized stress responses in plant tissues. As service providers scale up their pipelines, spatial biology is quickly becoming a standard requirement for comprehensive multi-omics studies.

Commercial Impact on Drug Discovery & Clinical Research

From a commercial perspective, the adoption of Spatially Resolved Transcriptomics has accelerated the pipeline for target identification and biomarker discovery. Pharmaceutical companies leverage spatial services to map drug distribution and cellular response within target tissues. By understanding exactly where a drug molecule localizes and how surrounding cells respond transcriptionally, developers can predict efficacy and toxicity with unprecedented accuracy. This spatial precision reduces attrition rates in early-stage clinical trials and optimizes patient stratification strategies.

Current Market Trends and Service Requirements

The global market for spatial biology is expanding rapidly. Researchers now demand end-to-end solutions that minimize batch effects and ensure data reproducibility. Consequently, service providers must offer highly robust and automated library preparation systems, sequencing platforms with diverse read lengths (such as Illumina, PacBio, and Oxford Nanopore), and comprehensive bioinformatics platforms capable of handling massive spatial datasets. Seamless integration of these components is crucial for successful sequencing service promotion.

About Biomarker Technologies

Biomarker Technologies (BMK)

A global leader in genomics, transcriptomics, and spatial multi-omics solutions.

Biomarker Technologies (BMKGene), founded in 2009, is a leading genomics service provider with over 16 years of continuous innovation in high-throughput sequencing and bioinformatics. Backed by more than 60 national invention patents and 200+ software copyrights, we deliver comprehensive multi-omics solutions—spanning genomics, metagenomics, epigenetics, single-cell omics, transcriptomics, and our proprietary BMKMANU S3000 spatial transcriptome technology—supported by our advanced BMKCloud bioinformatics platform. We have established long-term collaborations with organizations across 84 regions worldwide, providing reliable genomic solutions on a global scale.

Our Platforms

State-of-the-art sequencing and automation infrastructure ensuring data precision.

Leading, Multi-level High-throughput Sequencing Platforms

Multi-Level Sequencing Platforms

PacBio platforms: Sequel II, Sequel, RSII
Nanopore platforms: PromethION P48, GridION X5 MinION
10X Genomics: 10X ChromiumX, 10X Chromium Controller
Illumina platforms: NovaSeq
BGI-sequencing platforms: DNBSEQ-G400, DNBSEQ-T7
Bionano Irys system
Waters XEVO G2-XS QTOF
QTRAP 6500+

Professional, Automatic Molecular Laboratory

Over 20,000 Square Feet Place

Advanced biomolecular laboratory instruments.

Standard labs of sample extraction, library construction, clean rooms, and sequencing labs.

Standard procedures from sample extraction to sequencing under strict SOPs.

Multiple and flexible experimental designs fulfilling diverse research goals

Reliable Bioinformatic Analysis

Self-developed BMKCloud platform.

CPUs with 41,104 memory and 3 PB total storage.

4,260 computing cores with peak computing power over 121,708.8 Gflop per second.

Deep-Dive Application Scenarios of Spatial Transcriptomics

The versatility of Spatially Resolved Transcriptomics allows it to address critical questions across diverse biological domains. Here, we outline the primary applications where spatial profiling is delivering the most significant scientific impact:

1. Oncology and the Tumor Microenvironment (TME)

Tumors are highly complex, heterogeneous ecosystems composed of malignant cells, immune cells, stromal cells, and extracellular matrix components. Traditional sequencing methods homogenize these cells, losing spatial organization. With spatial transcriptomics, researchers can map the exact distribution of tumor-infiltrating lymphocytes (TILs), cancer-associated fibroblasts (CAFs), and immune checkpoints (e.g., PD-1/PD-L1) relative to tumor boundaries. This helps characterize the "hot" or "cold" immune status of tumors, providing crucial biomarkers to predict patient response to immunotherapies and discover novel therapeutic targets.

2. Neuroscience and Brain Mapping

The mammalian brain is defined by its intricate anatomical architecture and highly specialized regions. Mapping gene expression within these complex structures is essential for understanding neural function and disease. Spatially resolved transcriptomics allows the profiling of distinct cortical layers, hippocampal subfields, and complex nuclei. In neurodegenerative diseases like Alzheimer's and Parkinson's, researchers use spatial transcriptomics to study localized transcriptional changes in cells immediately adjacent to amyloid-beta plaques or neurofibrillary tangles, shedding light on the mechanisms of localized neuroinflammation and neuronal death.

3. Developmental Biology and Organogenesis

Embryonic development is a tightly coordinated process in both space and time. Cells differentiate and migrate along precise spatial gradients to form functional tissues and organs. Spatial transcriptomics offers a temporal-spatial window into organogenesis, allowing researchers to track cell lineage trajectories, morphogen gradients, and localized gene expression programs during embryonic development. This structural understanding is essential for advancing regenerative medicine and stem cell research.

4. Plant Biology and Agricultural Science

Unlike animal tissues, plant tissues possess rigid cell walls and unique cellular structures that pose challenges for single-cell isolation. Spatial transcriptomics overcomes these limitations by profiling intact plant tissue sections. Researchers can map gene expression in roots, stems, leaves, and floral organs to study developmental pathways, symbiotic relationships with microbiomes, and localized stress responses to environmental pressures such as drought, salinity, and pathogens. This spatial insight is key to breeding climate-resilient crop varieties and enhancing agricultural yields.

Advanced Automation

Fully Automated Platform for Next-Generation Sequencing: Brilliant Lab 1000

Pioneering automation in NGS library construction to deliver superior throughput and quality.

Biomarker technologies (BMKGENE) and PerkinElmer have jointly built a fully automated experimental production line, called Brilliant Lab 1000 (BL1000), which is applied to the high-throughput NGS library construction service.

BMKGENE strives to greatly improve the entire line of sequencing products in terms of product types, production line throughput, delivery quality, and cycle time, to provide customers with better sequencing services.

By minimizing manual intervention, the BL1000 platform guarantees high reproducibility, eliminates human error, and dramatically reduces turnaround times. This automated library preparation is critical for high-throughput spatial transcriptomics projects where sample integrity and consistent processing are key to obtaining reliable, publication-ready spatial data.

factory (8)
factory (9)
factory (1)
factory (3)
factory (2)
factory (4)
factory (5)
factory (6)
factory (7)

The Technical Landscape: BMKMANU S3000 Spatial Transcriptome

Our proprietary BMKMANU S3000 Spatial Transcriptome platform represents a significant leap forward in spatial resolution and capture efficiency. Built upon advanced spatial barcoding chemistry, the BMKMANU S3000 allows for the capture of full-length transcripts while maintaining sub-cellular resolution. By combining the strengths of next-generation sequencing and histological imaging, the platform enables researchers to align gene expression profiles directly with their tissue morphology.

Compared to traditional hybridization-based spatial techniques, which are limited to a predefined panel of genes, the BMKMANU S3000 offers an unbiased, transcriptome-wide discovery approach. This is crucial for identifying novel isoforms, non-coding RNAs, and rare transcripts that would otherwise go undetected in targeted panels. When integrated with our long-read sequencing technologies (such as PacBio and Oxford Nanopore), researchers can resolve full-length splice variants in their native spatial context, adding a new dimension of complexity to spatial biology.

Resolving the Computational Challenges of Spatial Biology

Generating millions of spatially barcoded reads per tissue section requires robust bioinformatics pipelines. The spatial transcriptomics workflow demands sophisticated algorithms for cell-type deconvolution, spatial domain clustering, and cell-cell communication modeling. BMKGene addresses these challenges by offering the self-developed BMKCloud platform. With over 4,260 computing cores and a peak computing power exceeding 121,708.8 Gflop/s, BMKCloud provides researchers with a seamless, user-friendly interface to run complex spatial analyses, visualize data, and generate publication-ready figures.

Enterprise Qualifications

Our Credentials and Patents

Demonstrating our commitment to quality, innovation, and industry standards.

Certification on Nanopore-based service provider
Certification on Nanopore-based service provider
Joint Laboratory between Biomarker Technologies Co., LTD and PerkinElmer Inc.
Joint Laboratory between Biomarker Technologies Co., LTD and PerkinElmer Inc.
Joint Laboratory of BioCloud Computing between Biomarker Technologies Co., LTD and Huazhong Agricultural University
Joint Laboratory of BioCloud Computing between Biomarker Technologies Co., LTD and Huazhong Agricultural University
Joint Laboratory of Biomarker Technologies Co., LTD, Pacific Biosciences of California Inc. and Gene Company Ltd.
Joint Laboratory of Biomarker Technologies Co., LTD, Pacific Biosciences of California Inc. and Gene Company Ltd.
Teaching Practice Base of Huazhong Agricultural University at Biomarker Technologies Co., LTD
Teaching Practice Base of Huazhong Agricultural University at Biomarker Technologies Co., LTD
National High and New Technology Enterprise Qualification
National High and New Technology Enterprise Qualification
National Academician Research Workstation
National Academician Research Workstation
Post-doctoral Research Workstation
Post-doctoral Research Workstation
ISO9001 quality certification
ISO9001 quality certification
ISO14001 Certification
ISO14001 Certification
OHSAS 18001 Certification
OHSAS 18001 Certification
Patent on bioinformatics task monitoring system
Patent on bioinformatics task monitoring system
Patent on BSA-based biomolecular marker discovery
Patent on BSA-based biomolecular marker discovery
Patent on high-density linkage map
Patent on high-density linkage map
Patent on plant genome DNA extraction method
Patent on plant genome DNA extraction method
Software copyright on Hi-C based genome assembly_00
Software copyright on Hi-C based genome assembly_00
Software copyright on species database construction
Software copyright on species database construction
Patent on BMKCloud based lncRNA sequencing analysis
Patent on BMKCloud based lncRNA sequencing analysis
Patent on BMKCloud
Patent on BMKCloud
Patent on genome de novo assembly
Patent on genome de novo assembly
Patent on high-throughput data analysis
Patent on high-throughput data analysis
Patent on RRS library construction
Patent on RRS library construction
Software copyright on Hi-C faciliated genome assembly
Software copyright on Hi-C faciliated genome assembly
Patent on Hi-C library construction
Patent on Hi-C library construction
Patent on non-reference genome based RNA sequencing analysis
Patent on non-reference genome based RNA sequencing analysis
Patent on SLAF-Seq related technique
Patent on SLAF-Seq related technique
Software copyright on microbiome analysis
Software copyright on microbiome analysis

For inquiries about our products or pricelist, please leave your email to us.

We will be in touch within 24 hours.

Inquiry Now

Send your message to us: